Publisher Correction: Gene expression imputation across multiple brain regions provides insights into schizophrenia risk (Nature Genetics, (2019), 51, 4, (659-674), 10.1038/s41588-019-0364-4);Gene expression imputation across multiple brain regions provides insights into schizophrenia risk

Nature Genetics

Volumn 51, Issue 4, 2019, Pages 659-674

  Huckins, Laura M ^a   Dobbyn, Amanda ^a   Ruderfer, Douglas M ^a,b,c   Hoffman, Gabriel ^a   Wang, Weiqing ^a   Pardiñas, Antonio F ^c   Rajagopal, Veera M ^d,e   Als, Thomas D ^d,e   T Nguyen, Hoang ^a   Girdhar, Kiran ^a   Boocock, James ^f   Roussos, Panos ^a   Fromer, Menachem ^a,w,x   Kramer, Robin ^g   Domenici, Enrico ^h,r   Gamazon, Eric R ^b,i   Purcell, Shaun ^a   Johnson, Jessica S ^a   Shah, Hardik R ^a   Klein, Lambertus L ^l   Dang, Kristen K ^m   Logsdon, Benjamin A ^m   Mahajan, Milind C ^a   Mangravite, Lara M ^m   Toyoshiba, Hiroyoshi ^o   Gur, Raquel E ^p   Hahn, Chang Gyu ^p   Schadt, Eric ^a   Lewis, David A ^l   Haroutunian, Vahram ^a,m,q   Peters, Mette A ^m   Lipska, Barbara K ^g   Buxbaum, Joseph D ^a   Hirai, Keisuke ^o   Perumal, Thanneer M ^m   Essioux, Laurent ^r   Ripke, Stephan ^w,x   Neale, Benjamin M ^w,x   Corvin, Aiden ^y   Walters, James T R ^c   Farh, Kai How ^w   Holmans, Peter A ^c,z   Lee, Phil ^w,x   Bulik Sullivan, Brendan ^w,x   Collier, David A ^aa,ab   Huang, Hailiang ^w,x   Pers, Tune H ^x,ac,ad   Agartz, Ingrid ^k,ae,af   Agerbo, Esben ^d,e   Albus, Margot ^ag   Alexander, Madeline ^ah   Amin, Farooq ^ai,aj   Bacanu, Silviu A ^ak   Begemann, Martin ^al   Belliveau, Richard A ^x   Bene, Judit ^am   Bergen, Sarah E ^k,x   Bevilacqua, Elizabeth ^x   Bigdeli, Tim B ^ak   Black, Donald W ^an   Bruggeman, Richard ^ao   Buccola, Nancy G ^ap   Buckner, Randy L ^w,aq   Byerley, William ^ar   Cahn, Wiepke ^as   Cai, Guiqing ^a   Campion, Dominique ^at   Cantor, Rita M ^f   Carr, Vaughan J ^au,av   Carrera, Noa ^c   Catts, Stanley V ^au,aw   Chambert, Kimberly D ^x   Chan, Raymond C K ^ax   Chen, Ronald Y L ^ay   Chen, Eric Y H ^ay,az   Cheng, Wei ^j   Cheung, Eric F C ^ba   Chong, Siow Ann ^bb   Cloninger, C Robert ^bc   Cohen, David ^bd   Cohen, Nadine ^be   Cormican, Paul ^y   Craddock, Nick ^c,z   Crowley, James J ^bf   Curtis, David ^bg,bh   Davidson, Michael ^bi   Davis, Kenneth L ^a   Degenhardt, Franziska ^bj,bk   Del Favero, Jurgen ^bl   Demontis, Ditte ^d,e   Dikeos, Dimitris ^bm   Dinan, Timothy ^bn   Djurovic, Srdjan ^af,bo   Donohoe, Gary ^y,bp   Drapeau, Elodie ^a   Duan, Jubao ^bq,br   Dudbridge, Frank ^bs   Durmishi, Naser ^bt   Eichhammer, Peter ^bu   Eriksson, Johan ^bv,bw,bx   Escott Price, Valentina ^c   Fanous, Ayman H ^by,bz,ca,cb   Farrell, Martilias S ^bf   Frank, Josef ^cc   Franke, Lude ^ao   Freedman, Robert ^cd   Freimer, Nelson B ^ce   Friedl, Marion ^cf   Friedman, Joseph I ^a   Genovese, Giulio ^x   Georgieva, Lyudmila ^c   Giegling, Ina ^cf,cg   Giusti Rodríguez, Paola ^bf   Godard, Stephanie ^ch   Goldstein, Jacqueline I ^w,x   Golimbet, Vera ^ci   Gopal, Srihari ^cj   Gratten, Jacob ^aw   de Haan, Lieuwe ^ck   Hammer, Christian ^al   Hamshere, Marian L ^c   Hansen, Mark ^cl   Hansen, Thomas ^e,s   Hartmann, Annette M ^cf   Henskens, Frans A ^au,cm,cn   Herms, Stefan ^bj,bk,co   Hirschhorn, Joel N ^x,ad,cp   Hoffmann, Per ^bj,bk,co   Hofman, Andrea ^bj,bk   Hollegaard, Mads V ^v   Hougaard, David M ^e,v   Ikeda, Masashi ^cq   Joa, Inge ^cr   Julia, Antonio ^cs   Kahn, Rene S ^as   Kalaydjieva, Luba ^ct,cu   Karachanak Yankova, Sena ^cv   Karjalainen, Juha ^ao   Kavanagh, David ^c   Keller, Matthew C ^cw   Kennedy, James L ^cx,cy,cz   Khrunin, Andrey ^da   Kim, Yunjung ^bf   Klovins, Janis ^db   Knowles, James A ^bz   Konte, Bettina ^cf   Kucinskas, Vaidutis ^dc   Kucinskiene, Zita Ausrele ^dc   Kuzelova Ptackova, Hana ^dd   Kahler, Anna K ^k   Laurent, Claudine ^ah,de   Keong, Jimmy Lee Chee ^bb,df   Lee, S Hong ^aw   Legge, Sophie E ^c   Lerer, Bernard ^dg   Li, Miaoxin ^ay,az,dh   Li, Tao ^di   Liang, Kung Yee ^dj   Lieberman, Jeffrey ^dk   Limborska, Svetlana ^da   Loughland, Carmel M ^au,cn   Lubinski, Jan ^dl   Lonnqvist, Jouko ^bx   Macek, Milan ^dd   Magnusson, Patrik K E ^k   Maher, Brion S ^dj   Maier, Wolfgang ^bk   Mallet, Jacques ^ch   Marsal, Sara ^cs   Mattheisen, Manuel ^d,e,bk   Mattingsdal, Morten ^af,dm   McCarley, Robert W ^cp,dn   McDonald, Colm ^bp   McIntosh, Andrew M ^do   Meier, Sandra ^cc   Meijer, Carin J ^ck   Melegh, Bela ^am   Melle, Ingrid ^af,bo   Mesholam Gately, Raquelle I ^cp,dp   Metspalu, Andres ^dq   Michie, Patricia T ^au,cn   Milani, Lili ^dq   Milanova, Vihra ^cv   Mokrab, Younes ^aa   Morris, Derek W ^y,bp   Mors, Ole ^d,e,u   Murphy, Kieran C ^dr   Murray, Robin M ^ab   Myin Germeys, Inez ^ds   Muller Myhsok, Bertram ^dt,du,dv   Nelis, Mari ^dq   Nenadic, Igor ^dw   Nertney, Deborah A ^aw   Nestadt, Gerald ^dx   Nicodemus, Kristin K ^y   Nikitina Zake, Liene ^db   Nisenbaum, Laura ^aa   Nordin, Annelie ^dy   O’Callaghan, Eadbhard ^dz   O’Dushlaine, Colm ^x   O’Neill, F Anthony ^ea   Oh, Sang Yun ^eb   Olincy, Ann ^cx   Olsen, Line ^e,w   Van Os, Jim ^ab,ds   Pantelis, Christos ^au,ec   Papadimitriou, George N ^bm   Papiol, Sergi ^al   Parkhomenko, Elena ^a   Pato, Michele T ^bz   Paunio, Tiina ^bx,ed   Pejovic Milovancevic, Milica ^ee   Perkins, Diana O ^bf   Pietiläinen, Olli ^bx,ed   Pimm, Jonathan ^bh   Pocklington, Andrew J ^c   Powell, John ^ab   Price, Alkes ^x,ef   Pulver, Ann E ^dx   Purcell, Shaun M ^a   Quested, Digby ^eg   Rasmussen, Henrik B ^s,aa   Reichenberg, Abraham ^a   Reimers, Mark A ^ak   Richards, Alexander L ^c   Roffman, Joshua L ^w   Salomaa, Veikko ^bx   Sanders, Alan R ^bq,br   Schall, Ulrich ^au,cn   Schubert, Christian R ^eh   Schulze, Thomas G ^cc,ei   Schwab, Sibylle G ^ej   Scolnick, Edward M ^x   Scott, Rodney J ^au,cn,ek   Seidman, Larry J ^dj,dp   Shi, Jianxin ^el   Sigurdsson, Engilbert ^em   Silagadze, Teimuraz ^en   Silverman, Jeremy M ^a,cb   Sim, Kang ^bb   Slominsky, Petr ^da   Smoller, Jordan W ^w,x   So, Hon Cheong ^ay   Spencer, Chris C A ^eo   Stahl, Eli A ^a   Stefansson, Hreinn ^ep   Steinberg, Stacy ^ep   Stogmann, Elisabeth ^eq   Straub, Richard E ^er   Strengman, Eric ^as,es   Strohmaier, Jana ^cc   Stroup, T Scott ^dk   Subramaniam, Mythily ^bb   Suvisaari, Jaana ^bx   Svrakic, Dragan M ^bc   Szatkiewicz, Jin P ^bf   Soderman, Erik ^k   Thirumalai, Srinivas ^et   Toncheva, Draga ^cv   Tosato, Sarah ^eu   Veijola, Juha ^ev,ew   Waddington, John ^dr   Walsh, Dermot ^ex   Wang, Dai ^cj   Wang, Qiang ^di   Webb, Bradley T ^ak   Weiser, Mark ^bi   Wildenauer, Dieter B ^ct   Williams, Nigel M ^c   Williams, Stephanie ^bf   Witt, Stephanie H ^cc   Wolen, Aaron R ^ak   Wong, Emily H M ^ay   Wormley, Brandon K ^ak   Xi, Hualin Simon ^eh   Zai, Clement C ^cx,cy   Zheng, Xuebin ^ey   Zimprich, Fritz ^eq   Wray, Naomi R ^aw   Stefansson, Kari ^ep   Visscher, Peter M ^aw   Adolfsson, Rolf ^dy   Andreassen, Ole A ^af,bo   Blackwood, Douglas H R ^do   Bramon, Elvira ^bh   Børglum, Anders D ^d,e,u   Cichon, Sven ^bj,bk,co,ez   Darvasi, Ariel ^fa   Ehrenreich, Hannelore ^al   Esko, Tonu ^x,ad,cp,dq   Gejman, Pablo V ^bq,br   Gill, Michael ^y   Gurling, Hugh ^bh   Hultman, Christina M ^k   Iwata, Nakao ^cq   Jablensky, Assen V ^au,ct,cu,fb   Jonsson, Erik G ^k,af   Kendler, Kenneth S ^ak   Kirov, George ^c   Knight, Jo ^cw,cy,cz   Lencz, Todd ^fc,fd,fe   Levinson, Douglas F ^ah   Li, Qingqin S ^cj   Liu, Jianjun ^ey,ff   Malhotra, Anil K ^fc,fd,fe   McCarroll, Steven A ^x,cp   McQuillin, Andrew ^bh   Moran, Jennifer L ^x   Mortensen, Preben Bo ^d,e   Mowry, Bryan J ^aw   Nothen, Markus M ^bj,bk   Ophoff, Roel A ^f,as,cd   Owen, Michael J ^c,z   Palotie, Aarno ^w,x,ed   Pato, Carlos N ^bz   Petryshen, Tracey L ^w,x,cp   Posthuma, Danielle ^fg,fh,fi   Rietschel, Marcella ^cc   Riley, Brien P ^ak   Rujescu, Dan ^cf,cg   Sham, Pak C ^ay,az,dh   Sklar, Pamela ^a   Clair, David St ^fj   Weinberger, Daniel R ^dx,er   Wendland, Jens R ^eh   Werge, Thomas ^e,s,t   Daly, Mark J ^w,x   Sullivan, Patrick F ^k,bf   O’Donovan, Michael C ^c,z   Rajagopal, Veera Manikandan ^d,e   Grove, Jakob ^d,e   Pedersen, Carsten Bøcker ^d,e   Pedersen, Marianne Giørtz ^d,e   Nordentoft, Merete ^e,t   Bybjerg Grauholm, Jonas ^e,v   Bækvad Hansen, Marie ^e,v   Hansen, Christine Søholm ^e,v   Sullivan, Patrick ^j,k   Devlin, Bernie ^l   Sieberts, Solveig K ^m   Cox, Nancy J ^b   Im, Hae Kyung ⁿ   more..

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^c Cardiff University   (United Kingdom)

^d AARHUS UNIVERSITY   (Denmark)

^e iPSYCH The Lundbeck Foundation Initiative for Integrated Psychiatric Research   (Denmark)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^h UNIVERSITY OF TRENTO   (Italy)

ⁱ UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^j UNIVERSITY OF NORTH CAROLINA   (United States)

^k KAROLINSKA INSTITUTE   (Sweden)

^l UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^m SAGE BIONETWORKS   (United States)

ⁿ UNIVERSITY OF CHICAGO   (United States)

^o TAKEDA PHARMACEUTICAL COMPANY LIMITED   (Japan)

^p UNIVERSITY OF PENNSYLVANIA   (United States)

^q JJ Peters Virginia Medical Center   (United States)

^r F HOFFMANN LA ROCHE LTD   (Switzerland)

^s Psychiatric Centre Sct Hans   (Denmark)

^t UNIVERSITY OF COPENHAGEN   (Denmark)

^u AARHUS UNIVERSITY HOSPITAL   (Denmark)

^v STATENS SERUM INSTITUT   (Denmark)

^w MASSACHUSETTS GENERAL HOSPITAL   (United States)

^x BROAD INSTITUTE OF MIT AND HARVARD   (United States)

^y TRINITY COLLEGE DUBLIN   (Ireland)

^z CARDIFF UNIVERSITY   (United Kingdom)

^aa ELI LILLY AND COMPANY   (United States)

^ab KING'S COLLEGE LONDON   (United Kingdom)

^ac TECHNICAL UNIVERSITY OF DENMARK   (Denmark)

^ad BOSTON CHILDREN S HOSPITAL   (United States)

^ae DIAKONHJEMMET HOSPITAL   (Norway)

^af UNIVERSITY OF OSLO   (Norway)

^ag KLINIKUM MÜNCHEN OST   (Germany)

^ah STANFORD UNIVERSITY   (United States)

^ai ATLANTA VA MEDICAL CENTER   (United States)

^aj EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^ak VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^al MAX PLANCK INSTITUTE OF EXPERIMENTAL MEDICINE   (Germany)

^am UNIVERSITY OF PÉCS   (Hungary)

^an UNIVERSITY OF IOWA   (United States)

^ao UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^ap LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^aq HARVARD UNIVERSITY   (United States)

^ar UNIVERSITY OF CALIFORNIA   (United States)

^as UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^at CHS du Rouvray   (France)

^au SCHIZOPHRENIA RESEARCH INSTITUTE   (Australia)

^av UNIVERSITY OF NEW SOUTH WALES   (Australia)

^aw UNIVERSITY OF QUEENSLAND   (Australia)

^ax INSTITUTE OF PSYCHOLOGY   (China)

^ay UNIVERSITY OF HONG KONG   (Hong Kong)

^az UNIVERSITY OF HONG KONG   (Hong Kong)

^ba CASTLE PEAK HOSPITAL   (Hong Kong)

^bb INSTITUTE OF MENTAL HEALTH   (Singapore)

^bc WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^bd ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^be Blue Note Biosciences   (United States)

^bf UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^bg QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^bh UNIVERSITY COLLEGE LONDON   (United Kingdom)

^bi SHEBA MEDICAL CENTER   (Israel)

^bj Life and Brain Center   (Germany)

^bk UNIVERSITY OF BONN   (Germany)

^bl UNIVERSITY OF ANTWERP   (Belgium)

^bm UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^bn UNIVERSITY COLLEGE CORK   (Ireland)

^bo OSLO UNIVERSITY HOSPITAL   (Norway)

^bp NATIONAL UNIVERSITY OF IRELAND   (Ireland)

^bq UNIVERSITY OF CHICAGO   (United States)

^br NORTHSHORE UNIVERSITY HEALTHSYSTEM   (United States)

^bs LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^bt University Clinic of Psychiatry   (Macedonia)

^bu UNIVERSITY OF REGENSBURG   (Germany)

^bv HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^bw FOLKHÄLSAN RESEARCH CENTER   (Finland)

^bx NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^by GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

^bz UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^ca VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^cb VETERANS AFFAIRS MEDICAL CENTER   (United States)

^cc MEDICAL FACULTY MANNHEIM HEIDELBERG UNIVERSITY   (Germany)

^cd UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^ce UNIVERSITY OF CALIFORNIA   (United States)

^cf MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^cg UNIVERSITY OF MUNICH   (Germany)

^ch PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^ci MENTAL HEALTH RESEARCH CENTER   (Russian Federation)

^cj Janssen Research and Development   (United States)

^ck ACADEMIC MEDICAL CENTER   (Netherlands)

^cl ILLUMINA INC   (United States)

^cm UNIVERSITY OF NEWCASTLE   (Australia)

^cn UNIVERSITY OF NEWCASTLE   (Australia)

^co UNIVERSITY OF BASEL   (Switzerland)

^cp HARVARD MEDICAL SCHOOL   (United States)

^cq FUJITA HEALTH UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^cr STAVANGER UNIVERSITY HOSPITAL   (Norway)

^cs HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^ct UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^cu UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^cv MEDICAL UNIVERSITY OF SOFIA   (Bulgaria)

^cw UNIVERSITY OF COLORADO   (United States)

^cx CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

^cy UNIVERSITY OF TORONTO   (Canada)

^cz UNIVERSITY OF TORONTO   (Canada)

^da INSTITUTE OF MOLECULAR GENETICS   (Russian Federation)

^db LATVIAN BIOMEDICAL RESEARCH AND STUDY CENTRE   (Latvia)

^dc VILNIUS UNIVERSITY   (Lithuania)

^dd UNIVERSITY HOSPITAL MOTOL   (Czech Republic)

^de SORBONNE UNIVERSITÉ   (France)

^df DUKE NUS MEDICAL SCHOOL   (Singapore)

^dg HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^dh UNIVERSITY OF HONG KONG   (Hong Kong)

^di SICHUAN UNIVERSITY   (China)

^dj JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^dk New York Presbyterian Morgan Stanley Children's Hospital   (United States)

^dl POMERANIAN MEDICAL UNIVERSITY   (Poland)

^dm Sørlandet Hospital   (Norway)

^dn Clinical Neuroscience Division   (United States)

^do UNIVERSITY OF EDINBURGH   (United Kingdom)

^dp BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^dq UNIVERSITY OF TARTU   (Estonia)

^dr ROYAL COLLEGE OF SURGEONS IN IRELAND   (Ireland)

^ds MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^dt UNIVERSITY OF LIVERPOOL   (United Kingdom)

^du MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

^dv Munich Cluster for Systems Neurology ^*  (Germany)

^dw JENA UNIVERSITY HOSPITAL   (Germany)

^dx JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^dy UMEÅ UNIVERSITY   (Sweden)

^dz DETECT   (Ireland)

^ea QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^eb UNIVERSITY OF CALIFORNIA   (United States)

^ec UNIVERSITY OF MELBOURNE   (Australia)

^ed UNIVERSITY OF HELSINKI   (Finland)

^ee UNIVERSITY OF BELGRADE   (Serbia)

^ef HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^eg UNIVERSITY OF OXFORD   (United Kingdom)

^eh PFIZER INC   (United States)

^ei UNIVERSITY OF GÖTTINGEN   (Germany)

^ej UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^ek HUNTER NEW ENGLAND HEALTH   (Australia)

^el NATIONAL CANCER INSTITUTE   (United States)

^em UNIVERSITY OF ICELAND   (Iceland)

^en TBILISI STATE MEDICAL UNIVERSITY   (Georgia)

^eo UNIVERSITY OF OXFORD   (United Kingdom)

^ep DECODE GENETICS   (Iceland)

^eq MEDICAL UNIVERSITY OF VIENNA   (Austria)

^er Lieber Institute for Brain Development Johns Hopkins Medical Campus   (United States)

^es UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^et BERKSHIRE HEALTHCARE NHS FOUNDATION TRUST   (United Kingdom)

^eu UNIVERSITY OF VERONA   (Italy)

^ev UNIVERSITY OF OULU   (Finland)

^ew OULU UNIVERSITY HOSPITAL   (Finland)

^ex HEALTH RESEARCH BOARD   (Ireland)

^ey GENOME INSTITUTE OF SINGAPORE   (Singapore)

^ez FORSCHUNGSZENTRUM JÜLICH   (Germany)

^fa HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^fb UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^fc FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH   (United States)

^fd DONALD AND BARBARA ZUCKER SCHOOL OF MEDICINE AT HOFSTRA NORTHWELL   (United States)

^fe ZUCKER HILLSIDE HOSPITAL   (United States)

^ff NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^fg ERASMUS MEDICAL CENTER   (Netherlands)

^fh VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^fi VU UNIVERSITY AMSTERDAM   (Netherlands)

^fj UNIVERSITY OF ABERDEEN   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AC110781.3 PROTEIN; ACTR5 PROTEIN; BETA N ACETYLHEXOSAMINIDASE; BETA N ACETYLHEXOSAMINIDASE A; CHRNA2 PROTEIN; DMC1 PROTEIN; EFTUD1P1 PROTEIN; FAM205A PROTEIN; FRAGILE X MENTAL RETARDATION PROTEIN; FURIN; GATAD2A PROTEIN; GNL3 PROTEIN; GUANOSINE TRIPHOSPHATASE; HIF1A PROTEIN; IGSF9B PROTEIN; IMMP2L PROTEIN; INO80E PROTEIN; METTL1 PROTEIN; MUTL PROTEIN HOMOLOG 1; NAGA PROTEIN; NMRAL1 PROTEIN; PITPNA PROTEIN; PLPPR5 PROTEIN; PROTEIN; SF3A1 PROTEIN; TAC3 PROTEIN; THOC7 PROTEIN; TIMM29 PROTEIN; TRANSCRIPTION FACTOR 4; TRANSCRIPTOME; UNCLASSIFIED DRUG;

ADULT; ANTERIOR CINGULATE; ANXIETY DISORDER; ARTICLE; BASAL GANGLION; BIPOLAR DISORDER; BRAIN REGION; CAUDATE NUCLEUS; CEREBELLUM; CEREBELLUM CORTEX; COMPARATIVE STUDY; CONTROLLED STUDY; DORSOLATERAL PREFRONTAL CORTEX; EXPRESSION QUANTITATIVE TRAIT LOCUS; FRONTAL CORTEX; GENE EXPRESSION; GENETIC ASSOCIATION; GENETIC RISK; GENOME-WIDE ASSOCIATION STUDY; HEMISPHERE; HIPPOCAMPUS; HUMAN; HYPERACTIVITY; HYPOPHYSIS; HYPOTHALAMUS; INTELLECTUAL IMPAIRMENT; MAJOR CLINICAL STUDY; MAJOR HISTOCOMPATIBILITY COMPLEX; MENTAL DISEASE; NEUROTRANSMISSION; NUCLEUS ACCUMBENS; PERINATAL PERIOD; PRENATAL PERIOD; PRIORITY JOURNAL; PUTAMEN; SCHIZOPHRENIA; THYROID GLAND; TRANSCRIPTOMICS; BRAIN; CASE CONTROL STUDY; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; PATHOPHYSIOLOGY; PROCEDURES; QUANTITATIVE TRAIT LOCUS; RISK; SINGLE NUCLEOTIDE POLYMORPHISM; ACCURACY; ENZYME ACTIVITY; GENOMICS; PREDICTION; PRENATAL DEVELOPMENT;

BRAIN; CASE-CONTROL STUDIES; GENE EXPRESSION; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; HUMANS; POLYMORPHISM, SINGLE NUCLEOTIDE; QUANTITATIVE TRAIT LOCI; RISK; SCHIZOPHRENIA; TRANSCRIPTOME;

EID: 85063585118     PISSN: 10614036     EISSN: 15461718     Source Type: Journal    
DOI: 10.1038/s41588-019-0435-6     Document Type: Erratum

References (94)

1. Nicolae, D. L. et al. Trait-associated SNPs are more likely to be eQTLs: annotation to enhance discovery from GWAS. PLoS Genet. 6, e1000888 (2010).
2. Dobbyn, A. et al. Co-localization of conditional eQTL and GWAS signatures in schizophrenia. Preprint at https://www.biorxiv.org/content/10.1101/129429v2 (2017).
3. Gilad, Y., Rifkin, S. A. & Pritchard, J. K. Revealing the architecture of gene regulation: the promise of eQTL studies. Trends Genet. 24, 408–415 (2008).
4. Cookson, W., Liang, L., Abecasis, G., Moffatt, M. & Lathrop, M. Mapping complex disease traits with global gene expression. Nat. Rev. Genet. 10, 184–194 (2009).
5. Albert, F. W. & Kruglyak, L. The role of regulatory variation in complex traits and disease. Nat. Rev. Genet. 16, 197–212 (2015).
6. Moffatt, M. F. et al. Genetic variants regulating ORMDL3 expression contribute to the risk of childhood asthma. Nature 448, 470–473 (2007).
7. Speliotes, E. K. et al. Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index. Nat. Genet. 42, 937–948 (2010).
8. Dubois, P. C. A. et al. Multiple common variants for celiac disease influencing immune gene expression. Nat. Genet. 42, 295–302 (2010).
9. Libioulle, C. et al. Novel Crohn disease locus identified by genome-wide association maps to a gene desert on 5p13.1 and modulates expression of PTGER4. PLoS Genet. 3, e58 (2007).
10. Giambartolomei, C. et al. Bayesian test for colocalisation between pairs of genetic association studies using summary statistics. PLoS Genet. 10, e1004383 (2014).
11. Boocock, J., Giambartolomei, C. & Stahl, E. A. COLOC2 (2016).
12. Zhu, Z. et al. Integration of summary data from GWAS and eQTL studies predicts complex trait gene targets. Nat. Genet. 48, 481–487 (2016).
13. Pickrell, J. K. et al. Detection and interpretation of shared genetic influences on 42 human traits. Nat. Genet. 48, 709–717 (2016).
14. Fromer, M. et al. Gene expression elucidates functional impact of polygenic risk for schizophrenia. Nat. Neurosci. 19, 1442–1453 (2016).
15. Gamazon, E. R. et al. A gene-based association method for mapping traits using reference transcriptome data. Nat. Genet. 47, 1091–1098 (2015).
16. Gusev, A. et al. Integrative approaches for large-scale transcriptome-wide association studies. Nat. Genet. 48, 245–252 (2016).
17. Geschwind, D. H. & Flint, J. Genetics and genomics of psychiatric disease. Science 349, 1489–94 (2015).
18. Leek, J. T., Johnson, W. E., Parker, H. S., Jaffe, A. E. & Storey, J. D. The sva package for removing batch effects and other unwanted variation in high-throughput experiments. Bioinformatics 28, 882–883 (2012).
19. Bennett, D. A., Schneider, J. A., Arvanitakis, Z. & Wilson, R. S. Overview and findings from the religious orders study. Curr. Alzheimer Res. 9, 628–645 (2012).
20. Bennett, D. A., Schneider, J. A., Buchman, A. S., Barnes, L. L. & Wilson, R. S. Overview and findings from the rush memory and aging project. Curr. Alzheimer Res. 9, 646–663 (2012).
21. Mele, M. et al. The human transcriptome across tissues and individuals. Science 348, 660–665 (2015).
22. Ripke, S. et al. Biological insights from 108 schizophrenia-associated genetic loci. Nature 511, 421–427 (2014).
23. Dobbyn, A. et al. Landscape of conditional eQTL in dorsolateral prefrontal cortex and Co-localization with schizophrenia GWAS. Am. J. Hum. Genet. 10.1016/j.ajhg.2018.04.011(2018).
24. Barbeira, A. N. et al. Exploring the phenotypic consequences of tissue specific gene expression variation inferred from GWAS summary statistics. Nat. Commun. 9, 1825 (2018).
25. Benjamin, Y. & Hochberg, Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. R. Stat. Soc. Series B Stat. Methodol. 57, 289–300 (1995).
26. Darnell, J. C. et al. FMRP stalls ribosomal translocation on mRNAs linked to synaptic function and autism. Cell 146, 247–261 (2011).
27. Fromer, M. et al. Gene expression elucidates functional impact of polygenic risk for schizophrenia. Nat. Neurosci. 19, 1442–1453 (2016).
28. Pardiñas, A. F. et al. Common schizophrenia alleles are enriched in mutation-intolerant genes and in regions under strong background selection. Nat. Genet. 50, 381–389 (2018).
29. Sanders, S. J. First glimpses of the neurobiology of autism spectrum disorder. Curr. Opin. Genet. Dev. 33, 80–92 (2015).
30. Monkol, Lek. et al. Analysis of protein-coding genetic variation in 60,706 humans. Nature 536, 285–291 (2016).
31. Malhotra, D. et al. High frequencies of de novo CNVs in bipolar disorder and schizophrenia. Neuron 72, 951–963 (2011).
32. Bautista, O., Vázquez-Caubet, J. C., Zhivago, E. A. & Dolores Sáiz, M. From metabolism to psychiatric symptoms: psychosis as a manifestation of acute intermittent porphyria. J. Neuropsychiatry Clin. Neurosci. 26, E30 (2014).
33. Zimmermann, M., Bonaccurso, C., Valerius, C. & Hamann, G. F. Acute intermittent porphyria. A clinical chameleon: case study of a 40-year-old female patient. Nervenarzt 77, 1501–1505 (2006).
34. Ventura, P. et al. A challenging diagnosis for potential fatal diseases: recommendations for diagnosing acute porphyrias. Eur. J. Intern. Med. 25, 497–505 (2014).
35. Pischik, E. & Kauppinen, R. An update of clinical management of acute intermittent porphyria. Appl. Clin. Genet. 8, 201–214 (2015).
36. Kumar, B. Acute intermittent porphyria presenting solely with psychosis: a case report and discussion. Psychosomatics 53, 494–498 (2012).
37. Bonnot, O. et al. Diagnostic and treatment implications of psychosis secondary to treatable metabolic disorders in adults: a systematic review. Orphanet J. Rare Dis. 9, 65 (2014).
38. Kaback, M. M. & Desnick, R. J. Hexosaminidase A Deficiency: GeneReviews (University of Washington, Seattle, 1993).
39. Osama, S. Late onset Tay-Sachs disease presenting as a brief psychotic disorder with catatonia: a case report and review of literature. Jefferson J. Psych. 15, 4 (2000).
40. Skaper, S. D. in Brain Protection in Schizophrenia, Mood and Cognitive Disorders (ed. Ritsner, M. S.) 135–165 (Springer Science & Business Media, 2010).
41. Castellano, E. et al. RAS signalling through PI3-Kinase controls cell migration via modulation of Reelin expression. Nat. Commun. 7, 11245 (2016).
42. Gururajan, A. & Buuse, M. van den. Is the mTOR-signalling cascade disrupted in Schizophrenia? J. Neurochem. 129, 377–387 (2014).
43. Ritsner, M. S. Brain Protection in Schizophrenia, Mood and Cognitive Disorders (Springer Science & Business Media, 2010).
44. Enriquez-Barreto, L. & Morales, M. The PI3K signaling pathway as a pharmacological target in Autism related disorders and Schizophrenia. Mol. Cell. Ther. 4, 2 (2016).
45. Glessner, J. T. et al. Strong synaptic transmission impact by copy number variations in schizophrenia. Proc. Natl Acad. Sci. USA 107, 10584–10589 (2010).
46. Network and Pathway Analysis Subgroup of Psychiatric Genomics Consortium. Psychiatric genome-wide association study analyses implicate neuronal, immune and histone pathways. Nat. Neurosci. 18, 199–209 (2015).
47. Bauman, A. L. et al. Cocaine and antidepressant-sensitive biogenic amine transporters exist in regulated complexes with protein phosphatase 2A. J. Neurosci. 20, 7571–7578 (2000).
48. Ayadi, A. et al. Mouse large-scale phenotyping initiatives: overview of the European Mouse Disease Clinic (EUMODIC) and of the Wellcome Trust Sanger Institute Mouse Genetics Project. Mamm. Genome 23, 600–610 (2012).
49. Keane, T. M. et al. Mouse genomic variation and its effect on phenotypes and gene regulation. Nature 477, 289–294 (2011).
50. Howe, D. G. et al. ZFIN, the zebrafish model organism database: increased support for mutants and transgenics. Nucleic Acids Res. 41, D854–D860 (2013).
51. Smith, C. L., Blake, J. A., Kadin, J. A., Richardson, J. E. & Bult, C. J. Mouse genome database (MGD)-2018: knowledgebase for the laboratory mouse. Nucleic Acids Res. 46, D836–D842 (2018).
52. Miller, J. A. et al. Transcriptional landscape of the prenatal human brain. Nature 508, 199–206 (2014).
53. Watts, D. J. & Strogatz, S. H. Collective dynamics of ‘small-world’ networks. Nature 393, 440–442 (1998).
54. Nguyen, H. T. et al. Integrated Bayesian analysis of rare exonic variants to identify risk genes for schizophrenia and neurodevelopmental disorders. Genome Med. 9, 114 (2017).
55. Mancuso, N. et al. Integrating gene expression with summary association statistics to identify genes associated with 30 complex traits. Am. J. Hum. Genet. 100, 473–487 (2017).
56. Gottlieb, A., Daneshjou, R., DeGorter, M., Montgomery, S. & Altman, R. Population-specific imputation of gene expression improves prediction of pharmacogenomic traits for African Americans. Preprint at https://www.biorxiv.org/content/10.1101/115451v1 (2017).
57. Need, A. & Goldstein, D. B. Next generation disparities in human genomics: concerns and remedies. Trends Genet 25, 489–494 (2009).
58. Popejoy, A. & Fullerton, S. Genomics is failing on diversity. Nature 538, 161–164 (2016).
59. Pardiñas, A. F. et al. Common schizophrenia alleles are enriched in mutation-intolerant genes and maintained by background selection. Preprint at https://www.biorxiv.org/content/10.1101/068593v1 (2016).
60. Browning, R. in The Poems of Robert Browning (eds Porter, C. & Clarke, H. A.) 257–271 (Thomas Y. Cromwell and Company, 1896).
61. Loftus, L. S. & Arnold, W. N. Vincent van Gogh’s illness: acute intermittent porphyria? BMJ 303, 1589–1591 (1991).
62. Strik, W. K. The psychiatric illness of Vincent van Gogh. Nervenarzt 68, 401–409 (1997).
63. Arnold, W. N. The illness of Vincent van Gogh. J. Hist. Neurosci. 13, 22–43 (2004).
64. Hughes, J. R. A reappraisal of the possible seizures of Vincent van Gogh. Epilepsy Behav. 6, 504–510 (2005).
65. Bhattacharyya, K. B. & Rai, S. The neuropsychiatric ailment of Vincent van Gogh. Ann. Indian Acad. Neurol. 18, 6–9 (2014).
66. Correa, R. Vincent van Gogh: A pathographic analysis. Med. Hypotheses 82, 141–144 (2014).
67. Peters, T. J. & Beveridge, A. The madness of King George III: a psychiatric re-assessment. Hist. Psychiatry 21, 20–37 (2010).
68. Szatkiewicz, J. P. et al. Copy number variation in schizophrenia in Sweden. Mol. Psychiatry 19, 762–773 (2014).
69. Fromer, M. et al. De novo mutations in schizophrenia implicate synaptic networks. Nature 506, 179–184 (2014).
70. Cross-Disorder Group of the Psychiatric Genomics Consortium. Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis. Lancet 381, 1371–1379 (2013).
71. Keefe, R. S. E. & Fenton, W. S. How should DSM-V criteria for schizophrenia include cognitive impairment? Schizophr. Bull. 33, 912–920 (2007).
72. Reichenberg, A. et al. Static and dynamic cognitive deficits in childhood preceding adult schizophrenia: a 30-year study. Am. J. Psychiatry 167, 160–169 (2010).
73. Gold, J. M. Cognitive deficits as treatment targets in schizophrenia. Schizophr. Res. 72, 21–28 (2004).
74. Cannon, M. et al. Evidence for early-childhood, pan-developmental impairment specific to schizophreniform disorder. Arch. Gen. Psychiatry 59, 449 (2002).
75. Parikshak, N. N., Gandal, M. J., Geschwind, D. H. & Angeles, L. Systems biology and gene networks in neurodevelopmental and neurodegenerative disorders. Nat. Rev. Genet. 16, 441–458 (2015).
76. Glass, D. et al. Gene expression changes with age in skin, adipose tissue, blood and brain. Genome Biol. 14, R75 (2013).
77. Colantuoni, C. et al. Temporal dynamics and genetic control of transcription in the human prefrontal cortex. Nature 478, 519–523 (2012).
78. Gusev, A. et al. Transcriptome-wide association study of schizophrenia and chromatin activity yields mechanistic disease insights. Preprint at https://www.biorxiv.org/content/10.1101/067355v1 (2016).
79. Ardlie, K. G. et al. The genotype-tissue expression (GTEx) pilot analysis: multitissue gene regulation in humans. Science 348, 648–660 (2015).
80. Willer, C. J., Li, Y. & Abecasis, G. R. METAL: fast and efficient meta-analysis of genomewide association scans. Bioinformatics 26, 2190–2191 (2010).
81. COCHRAN, W. G. THE comparison of percentages in matched samplES. Biometrika 37, 256–266 (1950).
82. Yang, J., Lee, S. H., Goddard, M. E. & Visscher, P. M. GCTA: a tool for genome-wide complex trait analysis. Am. J. Hum. Genet. 88, 76–82 (2011).
83. de Leeuw, C. A., Mooij, J. M., Heskes, T. & Posthuma, D. MAGMA: generalized gene-set analysis of GWAS data. PLoS Comput. Biol. 11, e1004219 (2015).
84. Kirov, G. et al. De novo CNV analysis implicates specific abnormalities of postsynaptic signalling complexes in the pathogenesis of schizophrenia. Mol. Psychiatry 17, 142–153 (2012).
85. Ashburner, M. et al. Gene ontology: tool for the unification of biology. the gene ontology consortium. Nat. Genet. 25, 25–29 (2000).
86. The Gene Ontology Consortium. Gene ontology consortium: going forward. Nucleic Acids Res. 43, D1049–D1056 (2014).
87. Kanehisa, M. & Goto, S. KEGG: Kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 28, 27–30 (2000).
88. Croft, D. et al. The Reactome pathway knowledgebase. Nucleic Acids Res. 42, D472–D477 (2014).
89. Thomas, P. D. et al. PANTHER: a library of protein families and subfamilies indexed by function. Genome Res. 13, 2129–2141 (2003).
90. Mi, H., Muruganujan, A. & Thomas, P. D. PANTHER in 2013: modeling the evolution of gene function, and other gene attributes, in the context of phylogenetic trees. Nucleic Acids Res. 41, D377–D386 (2013).
91. Lin, G. N. et al. Spatiotemporal 16p11.2 Protein network implicates cortical late mid-fetal brain development and KCTD13- Cul3-RhoA pathway in psychiatric diseases. Neuron 85, 742–754 (2015).
92. Bahl, E., Koomar, T. & Michaelson, J. J. cerebroViz: An R package for anatomical visualization of spatiotemporal brain data. Bioinformatics 33, btw726 (2016).
93. van der Weyden, L., White, J. K., Adams, D. J. & Logan, D. W. The mouse genetics toolkit: revealing function and mechanism. Genome Biol. 12, 224 (2011).
94. Brown, S. D. M. & Moore, M. W. The international mouse phenotyping consortium: past and future perspectives on mouse phenotyping. Mamm. Genome 23, 632–640 (2012).